speb/financial-data huggingface dataset:
SUZ income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -13118498000.00
SUZ balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 24875787.00
SUZ balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 24875787.00
SUZ balance_sheet (annual, 2024-12-31) — Treasury Stock: 1339197000.00
SUZ balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 1339197000.00
SUZ balance_sheet (annual, 2024-12-31) — Work In Process: 135380000.00
SUZ balance_sheet (quarterly, 2024-12-31) — Work In Process: 135380000.00
SUZ balance_sheet (annual, 2024-12-31) — Working Capital: 17705022000.00
SUZ balance_sheet (quarterly, 2024-12-31) — Working Capital: 17705022000.00
SUZ income_statement (quarterly, 2025-03-31) — +Operating Expense: 1396472000.00
SUZ income_statement (quarterly, 2025-03-31) — +Total Revenue: 11552921000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5669809000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 6354237000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -34893437000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -34242000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 1006820000.00
SUZ income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1239071000.00
SUZ income_statement (quarterly, 2025-03-31) — Basic EPS: 5.12
SUZ cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 9018818000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 14376555000.00
SUZ cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3079916000.00
SUZ cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -1836180000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 6851519000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Capital Stock: 19235546000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 9914505000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 16430828000.00
SUZ cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
SUZ balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 1595620000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Cash Financial: 8318885000.00
SUZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -6598817000.00
SUZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 3324203000.00
SUZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 4417690000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -91408000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -528881000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 5303000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Inventory: -430784000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 183194000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -41443000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Payable: -86105000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -614986000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Receivables: 2162650000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 5303000.00
SUZ cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1258631000.00
SUZ cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 2238113000.00
SUZ cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1143076000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Common Stock: 19235546000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 38398266000.00
SUZ cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -38664000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 3461204000.00
SUZ income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 7729167000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 702399000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Current Assets: 34479115000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 870322000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Current Debt: 3428610000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4298932000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 213338000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 213338000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 13189891000.00
SUZ cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 3539970000.00
SUZ cash_flow (quarterly, 2025-03-31) — Deferred Tax: 3539970000.00
SUZ income_statement (quarterly, 2025-03-31) — Depletion Income Statement: 2532000.00
SUZ cash_flow (quarterly, 2025-03-31) — Depreciation: 2497422000.00
SUZ cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2497422000.00
SUZ income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 273834000.00
SUZ cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2497422000.00
SUZ income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 273834000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 5570354000.00
SUZ income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1242242000.00
SUZ income_statement (quarterly, 2025-03-31) — Diluted EPS: 5.10
SUZ income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 6340760000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 7699000.00
SUZ income_statement (quarterly, 2025-03-31) — EBIT: 11431631000.00
SUZ income_statement (quarterly, 2025-03-31) — EBITDA: 13929053000.00
SUZ income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -17077000.00
SUZ cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 17077000.00
SUZ cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -247389000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 1091927000.00
SUZ cash_flow (quarterly, 2025-03-31) — End Cash Position: 9914505000.00
SUZ income_statement (quarterly, 2025-03-31) — Excise Taxes: 530295000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Financial Assets: 3244326000.00
SUZ cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -6598817000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Finished Goods: 3938610000.00
SUZ cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1337774000.00
SUZ cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -3693159000.00
SUZ cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 46307000.00
SUZ income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -46307000.00
SUZ income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 8897445000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 14176925000.00
SUZ income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 733464000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Goodwill: 8416435000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 13887712000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 6388479000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Gross PPE: 105148694000.00
SUZ income_statement (quarterly, 2025-03-31) — Gross Profit: 3823754000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 888004000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 71201000.00
SUZ income_statement (quarterly, 2025-03-31) — Interest Expense: 1476383000.00
SUZ income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1476383000.00
SUZ income_statement (quarterly, 2025-03-31) — Interest Income: 348428000.00
SUZ income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 348428000.00
SUZ cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -2192903000.00
SUZ cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -2014500000.00
SUZ cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 361942000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -95111000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Inventory: 8642882000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Invested Capital: 129440837000.00
SUZ cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 3324203000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1006820000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1427438000.00
SUZ cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 7055244000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 20376594000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 5981197000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 87613961000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 93595158000.00
SUZ cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 7055244000.00
SUZ cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -11547052000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 420618000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 2943436000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 64928013000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Minority Interest: 137380000.00
SUZ income_statement (quarterly, 2025-03-31) — Minority Interests: -7418000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -38664000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Net Debt: 81128066000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -5204286000.00
SUZ income_statement (quarterly, 2025-03-31) — Net Income: 6340760000.00
SUZ income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 6340760000.00
SUZ income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 6348178000.00
SUZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 6340760000.00
SUZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 6340760000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 6348178000.00
SUZ income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 6348178000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -11836000.00
SUZ income_statement (quarterly, 2025-03-31) — Net Interest Income: -1201232000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 6367566000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -4491808000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -4491808000.00
SUZ income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1201232000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 124558000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -6998000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Net PPE: 70255257000.00
SUZ cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1188349000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 24510554000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 1042971000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 4431946000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 74715000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 74715000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 4431946000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
SUZ balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 730032000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 2496154000.00
SUZ income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 5182778000.00
SUZ income_statement (quarterly, 2025-03-31) — Normalized Income: 763509635.47
SUZ cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 4417690000.00
SUZ cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -8834061000.00
SUZ income_statement (quarterly, 2025-03-31) — Operating Income: 2427282000.00
SUZ income_statement (quarterly, 2025-03-31) — Operating Revenue: 13931964000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1238661686.00
SUZ balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 665543000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 3428610000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1943647000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 14176925000.00
SUZ income_statement (quarterly, 2025-03-31) — Other Gand A: 240269000.00
SUZ income_statement (quarterly, 2025-03-31) — Other Income Expense: 8729198000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 5471277000.00
SUZ cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1332297000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 23979966000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 243758000.00
SUZ income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 520000.00
SUZ income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -34493000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Other Properties: 2006328000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 6516323000.00
SUZ income_statement (quarterly, 2025-03-31) — Other Special Charges: 104863000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Payables: 6031575000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 6733974000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 85581000.00
SUZ income_statement (quarterly, 2025-03-31) — Pretax Income: 9955248000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SUZ cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 86879000.00
SUZ cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
SUZ cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -11836000.00
SUZ cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1231900000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Raw Materials: 4656697000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Receivables: 7766277000.00
SUZ income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5505579000.00
SUZ income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2497422000.00
SUZ cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -11547052000.00
SUZ cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -38664000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 6357219000.00
SUZ income_statement (quarterly, 2025-03-31) — Salaries And Wages: 493195000.00
SUZ cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 43551000.00
SUZ income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 423667000.00
SUZ income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1157131000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Share Issued: 1264117615.00
SUZ income_statement (quarterly, 2025-03-31) — Special Income Charges: -151170000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 38398266000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 24510554000.00
SUZ income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 3169024635.47
SUZ income_statement (quarterly, 2025-03-31) — Tax Provision: 3607070000.00
SUZ income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.36
SUZ balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 1412040000.00
SUZ cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -159068000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Total Assets: 155244885000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 126012227000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Total Debt: 97894090000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 38535646000.00
SUZ income_statement (quarterly, 2025-03-31) — Total Expenses: 9125639000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 116709239000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 120765770000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 103519348000.00
SUZ income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 2259035000.00
SUZ income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 73277000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 354067000.00
SUZ income_statement (quarterly, 2025-03-31) — Total Unusual Items: 8746275000.00
SUZ income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 8746275000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 25455929.00
SUZ balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 1371424000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Work In Process: 142686000.00
SUZ balance_sheet (quarterly, 2025-03-31) — Working Capital: 21289224000.00
SUZ income_statement (quarterly, 2025-06-30) — +Operating Expense: 1640622000.00
SUZ income_statement (quarterly, 2025-06-30) — +Total Revenue: 13295895000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5951839000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 7287028000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 931722000.00
SUZ income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1235959094.00
SUZ income_statement (quarterly, 2025-06-30) — Basic EPS: 4.05
SUZ cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 9914505000.00
SUZ cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3202992000.00
SUZ cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -1806250000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 6787997000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Capital Stock: 19235546000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 12283589000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 20371439000.00
SUZ cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
SUZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 3087333000.00
SUZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -4856952000.00
SUZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 4340575000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 496643000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 158545000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: 308610000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Inventory: 28425000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -277259000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -168735000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Payable: 805253000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 963798000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1483166000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: 308610000.00
SUZ cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -936937000.00
SUZ cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -1341979000.00
SUZ cash_flow (quarterly, 2025-06-30) — Changes In Cash: 2570956000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Common Stock: 19235546000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 43137811000.00
SUZ cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -153254000.00
SUZ income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8608124000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 857033000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Current Assets: 39909114000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 838023000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Current Debt: 2881840000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3719863000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 146569000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 146569000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 12616956000.00
SUZ cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 2044722000.00
SUZ cash_flow (quarterly, 2025-06-30) — Deferred Tax: 2044722000.00
SUZ cash_flow (quarterly, 2025-06-30) — Depreciation: 2839264000.00
SUZ cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2839264000.00
SUZ cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2839264000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 4606340000.00
SUZ income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1239037379.00
SUZ income_statement (quarterly, 2025-06-30) — Diluted EPS: 4.04
SUZ income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 5004695000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 1997000.00
SUZ cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 8835000.00
SUZ income_statement (quarterly, 2025-06-30) — EBIT: 8906548000.00
SUZ income_statement (quarterly, 2025-06-30) — EBITDA: 11745812000.00
SUZ income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -172005000.00
SUZ cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 172005000.00
SUZ cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -201872000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 1069606000.00
SUZ cash_flow (quarterly, 2025-06-30) — End Cash Position: 12283589000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Financial Assets: 4055943000.00
SUZ cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 3087333000.00
SUZ cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1137583000.00
SUZ cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -2659346000.00
SUZ cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 77792000.00
SUZ income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 5648145000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 13982160000.00
SUZ income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 647466000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 13603820000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Gross PPE: 106242522000.00
SUZ income_statement (quarterly, 2025-06-30) — Gross Profit: 4687771000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 1100397000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 280624000.00
SUZ income_statement (quarterly, 2025-06-30) — Interest Expense: 1606439000.00
SUZ income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1606439000.00
SUZ income_statement (quarterly, 2025-06-30) — Interest Income: 383259000.00
SUZ income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 383259000.00
SUZ cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -15251000.00
SUZ cash_flow (quarterly, 2025-06-30) — Interest Paid Cfo: -872840000.00
SUZ cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 220884000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Inventory: 8619236000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Invested Capital: 134764967000.00
SUZ cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -4856952000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 931722000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1225435000.00
SUZ cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 5605949000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 5949974000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 88745316000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 94695290000.00
SUZ cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 5605949000.00
SUZ cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -2504834000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 293713000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 2847436000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Minority Interest: 133494000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -7339000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -153254000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Net Debt: 79343567000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -2988799000.00
SUZ income_statement (quarterly, 2025-06-30) — Net Income: 5004695000.00
SUZ income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 5004695000.00
SUZ income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 5011953000.00
SUZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 5004695000.00
SUZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 5004695000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 5011953000.00
SUZ income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 5011953000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -10243000.00
SUZ income_statement (quarterly, 2025-06-30) — Net Interest Income: -1223180000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -1572721000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 3101115000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 3101115000.00
SUZ income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1223180000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 154723000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -117642000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Net PPE: 70254542000.00
SUZ cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1351592000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 29533991000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 962263000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 2376910000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 74715000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 74715000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 2376910000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 0.00
SUZ balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 738016000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 2604168000.00
SUZ income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 6097667000.00
SUZ income_statement (quarterly, 2025-06-30) — Normalized Income: 1126912178.24
SUZ cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 4340575000.00
SUZ cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -5398348000.00
SUZ income_statement (quarterly, 2025-06-30) — Operating Income: 3047149000.00
SUZ income_statement (quarterly, 2025-06-30) — Operating Revenue: 13295895000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1235908788.00
SUZ balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 994602000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 2881370000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1448366000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 13982160000.00
SUZ income_statement (quarterly, 2025-06-30) — Other Gand A: 647466000.00
SUZ income_statement (quarterly, 2025-06-30) — Other Income Expense: 5476140000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 5230500000.00
SUZ cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1435723000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 24430698000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 241245000.00
SUZ income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 154906000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Other Properties: 2046425000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 8087850000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Payables: 6445125000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 7302158000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 88514000.00
SUZ income_statement (quarterly, 2025-06-30) — Pretax Income: 7300109000.00
SUZ cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 19755000.00
SUZ cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -7339000.00
SUZ cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -10243000.00
SUZ cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1386499000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Receivables: 8734926000.00
SUZ income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 8608124000.00
SUZ income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2839264000.00
SUZ cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -2504834000.00
SUZ cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -153254000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 11431251000.00
SUZ cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 34907000.00
SUZ income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 838250000.00
SUZ income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1485716000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Share Issued: 1264117615.00
SUZ balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 43137811000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 29533991000.00
SUZ income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 1770362178.24
SUZ income_statement (quarterly, 2025-06-30) — Tax Provision: 2288156000.00
SUZ income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.31
SUZ balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1447898000.00
SUZ cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -23601000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Total Assets: 159422893000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 131883127000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Total Debt: 98415153000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 43271305000.00
SUZ income_statement (quarterly, 2025-06-30) — Total Expenses: 10248746000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 116151588000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 119513779000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 103534632000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 491289000.00
SUZ income_statement (quarterly, 2025-06-30) — Total Unusual Items: 5648145000.00
SUZ income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 5648145000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 28208827.00
SUZ balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 1511146000.00
SUZ balance_sheet (quarterly, 2025-06-30) — Working Capital: 27292158000.00
SUZ income_statement (quarterly, 2025-09-30) — EBITDA: 7734262000.00
SUZ income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 5321161000.00
SUZ income_statement (annual, 2025-12-31) — +Operating Expense: 6144028000.00
SUZ income_statement (quarterly, 2025-12-31) — +Operating Expense: 1492102000.00
SUZ income_statement (annual, 2025-12-31) — +Total Revenue: 50115679000.00
SUZ income_statement (quarterly, 2025-12-31) — +Total Revenue: 13113718000.00
SUZ balance_sheet (annual, 2025-12-31) — Accounts Payable: 5141386000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5141386000.00
SUZ balance_sheet (annual, 2025-12-31) — Accounts Receivable: 6560607000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 6560607000.00
SUZ balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -37961232000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -37961232000.00
SUZ balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -131548000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -131548000.00
SUZ balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 901181000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 901181000.00
SUZ income_statement (annual, 2025-12-31) — Basic Average Shares: 1236702000.00
SUZ income_statement (quarterly, 2025-12-31) — Basic Average Shares: 1235908788.00
SUZ income_statement (annual, 2025-12-31) — Basic EPS: 10.84
SUZ income_statement (quarterly, 2025-12-31) — Basic EPS: 0.09
SUZ cash_flow (annual, 2025-12-31) — Beginning Cash Position: 9018818000.00
SUZ cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 15838866000.00
SUZ balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 14780550000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 14780550000.00
SUZ cash_flow (annual, 2025-12-31) — Capital Expenditure: -12574801000.00
SUZ cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -2808907000.00
SUZ cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -7913483000.00
SUZ cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -1631733000.00
SUZ balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 6929890000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 6929890000.00
SUZ balance_sheet (annual, 2025-12-31) — Capital Stock: 24235546000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Capital Stock: 24235546000.00
SUZ balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 15179753000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 15179753000.00
SUZ balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 25112527000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 25112527000.00
SUZ cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
SUZ cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
SUZ balance_sheet (annual, 2025-12-31) — Cash Equivalents: 5298427000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 5298427000.00
SUZ balance_sheet (annual, 2025-12-31) — Cash Financial: 9881326000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Cash Financial: 9881326000.00
SUZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1819627000.00
SUZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1434307000.00
SUZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -9832727000.00
SUZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -5027810000.00
SUZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 18152175000.00
SUZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5359653000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Account Payable: 6630000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -94792000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -91499000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 73047000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 384227000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 97072000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Inventory: -216357000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Inventory: 514580000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 259705000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 388324000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -218901000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -17273000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Payable: 390857000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Payable: 2280000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 299358000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 75327000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Receivables: 1173191000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Receivables: -369180000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Tax Payable: 384227000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 97072000.00
SUZ cash_flow (annual, 2025-12-31) — Change In Working Capital: 1296996000.00
SUZ cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 591778000.00
SUZ cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1586613000.00
SUZ cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -290026000.00
SUZ cash_flow (annual, 2025-12-31) — Changes In Cash: 6499821000.00
SUZ cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1102464000.00
SUZ balance_sheet (annual, 2025-12-31) — Common Stock: 24235546000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Common Stock: 24235546000.00
SUZ balance_sheet (annual, 2025-12-31) — Common Stock Equity: 43812045000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 43812045000.00
SUZ cash_flow (annual, 2025-12-31) — Common Stock Payments: -191918000.00
SUZ cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
SUZ balance_sheet (annual, 2025-12-31) — Construction In Progress: 2764799000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 2764799000.00
SUZ income_statement (annual, 2025-12-31) — Cost Of Revenue: 33889504000.00
SUZ income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9098452000.00
SUZ balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1132713000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1132713000.00
SUZ balance_sheet (annual, 2025-12-31) — Current Assets: 43867069000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Current Assets: 43867069000.00
SUZ balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 857810000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 857810000.00
SUZ balance_sheet (annual, 2025-12-31) — Current Debt: 3004905000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Current Debt: 3004905000.00
SUZ balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 3862715000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 3862715000.00
SUZ balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 132408000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 132408000.00
SUZ balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 132408000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 132408000.00
SUZ balance_sheet (annual, 2025-12-31) — Current Liabilities: 13772871000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 13772871000.00
SUZ cash_flow (annual, 2025-12-31) — Deferred Income Tax: 6455108000.00
SUZ cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -27605000.00
SUZ cash_flow (annual, 2025-12-31) — Deferred Tax: 6455108000.00
SUZ cash_flow (quarterly, 2025-12-31) — Deferred Tax: -27605000.00
SUZ income_statement (annual, 2025-12-31) — Depletion Income Statement: -14127000.00
SUZ income_statement (quarterly, 2025-12-31) — Depletion Income Statement: -6917000.00
SUZ cash_flow (annual, 2025-12-31) — Depreciation: 11297258000.00
SUZ cash_flow (quarterly, 2025-12-31) — Depreciation: 3071041000.00
SUZ cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 11297258000.00
SUZ cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3071041000.00
SUZ income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1086796000.00
SUZ income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 271413000.00
SUZ cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 11297258000.00
SUZ cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3071041000.00
SUZ income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1100923000.00
SUZ income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 278330000.00
SUZ balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 8136320000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 8136320000.00
SUZ income_statement (annual, 2025-12-31) — Diluted Average Shares: 1239714000.00
SUZ income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1235908788.00
SUZ income_statement (annual, 2025-12-31) — Diluted EPS: 10.82
SUZ income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.09
SUZ income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 13408189000.00
SUZ income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 109218000.00
SUZ balance_sheet (annual, 2025-12-31) — Dividends Payable: 1393121000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 1393121000.00
SUZ cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 8835000.00
SUZ cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 0.00
SUZ income_statement (annual, 2025-12-31) — EBIT: 26558100000.00
SUZ income_statement (quarterly, 2025-12-31) — EBIT: 1739701000.00
SUZ income_statement (annual, 2025-12-31) — EBITDA: 37855358000.00
SUZ income_statement (quarterly, 2025-12-31) — EBITDA: 4810742000.00
SUZ income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -409212000.00
SUZ income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -140862000.00
SUZ cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 409212000.00
SUZ cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 140862000.00
SUZ cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -338886000.00
SUZ cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 443351000.00
SUZ balance_sheet (annual, 2025-12-31) — Employee Benefits: 1073465000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1073465000.00
SUZ cash_flow (annual, 2025-12-31) — End Cash Position: 15179753000.00
SUZ cash_flow (quarterly, 2025-12-31) — End Cash Position: 15179753000.00
SUZ income_statement (annual, 2025-12-31) — Excise Taxes: 2309904000.00
SUZ income_statement (quarterly, 2025-12-31) — Excise Taxes: 626531000.00
SUZ balance_sheet (annual, 2025-12-31) — Financial Assets: 8014683000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Financial Assets: 8014683000.00
SUZ cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1819627000.00
SUZ cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1434307000.00
SUZ balance_sheet (annual, 2025-12-31) — Finished Goods: 3453490000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Finished Goods: 3453490000.00
SUZ cash_flow (annual, 2025-12-31) — Free Cash Flow: 5577374000.00
SUZ cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 2550746000.00
SUZ cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -7328684000.00
SUZ cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 102938000.00
SUZ cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 475267000.00
SUZ cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 203039000.00
SUZ income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -386396000.00
SUZ income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -199477000.00
SUZ income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 14879294000.00
SUZ income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -2079397000.00
SUZ balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 21087645000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 21087645000.00
SUZ income_statement (annual, 2025-12-31) — General And Administrative Expense: 3036427000.00
SUZ income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 863859000.00
SUZ balance_sheet (annual, 2025-12-31) — Goodwill: 8221723000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Goodwill: 8221723000.00
SUZ balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 13000076000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 13000076000.00
SUZ balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 6692155000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 6692155000.00
SUZ balance_sheet (annual, 2025-12-31) — Gross PPE: 107589208000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Gross PPE: 107589208000.00
SUZ income_statement (annual, 2025-12-31) — Gross Profit: 16226175000.00
SUZ income_statement (quarterly, 2025-12-31) — Gross Profit: 4015266000.00
SUZ balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 1556978000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 1556978000.00
SUZ income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: -1516458000.00
SUZ balance_sheet (annual, 2025-12-31) — Income Tax Payable: 218238000.00
SUZ balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 218238000.00
SUZ income_statement (annual, 2025-12-31) — Interest Expense: 6146926000.00
SUZ income_statement (quarterly, 2025-12-31) — Interest Expense: 1605200000.00
SUZ income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 6146926000.00
SUZ income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1605200000.00
SUZ income_statement (annual, 2025-12-31) — Interest Income: 1584056000.00
SUZ income_statement (quarterly, 2025-12-31) — Interest Income: 439811000.00
SUZ income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1584056000.00
SUZ income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 439811000.00
SUZ cash_flow (annual, 2025-12-31) — Interest Paid Cff: -2208158000.00
SUZ cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: 0.00
SUZ cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -5817907000.00
SUZ cash_flow (quarterly, 2025-12-31) — Interest Paid Cfo: -1064675000.00
SUZ cash_flow (annual, 2025-12-31) — Interest Received Cfo: 1213789000.00
SUZ cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: 244648000.00
SUZ balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -208091000.00